Segal McCambridge Shareholder Jeffrey Singer Named to Faculty of HB's Pharmaceutical Litigation Crash Course


September 22, 2009

Segal McCambridge Shareholder Jeffrey Singer has been engaged to speak at the Pharmaceutical Litigation Crash Course to be presented by HB Litigation Conferences on October 28, 2009. This program will be delivered via teleconference.

Intended as a primer for lawyers and paralegals new to pharmaceutical litigation, the program will cover such topics as the history of drug litigation, the finer points of working with experts, how to calculate and prove damages, and negotiating a settlement, among other subjects.

For more information on the program or to register, click here.